Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Rare Cannabinoid Company Launches THC + CBG Relief Gummies - The Ultimate Edible for Physical Wellness


News provided by

Rare Cannabinoid Company

Nov 29, 2023, 04:43 ET

Share this article

Share toX

Share this article

Share toX

New THC + CBG Relief Gummies from Rare Cannabinoid Company contain hemp-derived Delta-9-THC, CBG oil, and CBD. They are all natural, vegan, and flavored with green apple.
New THC + CBG Relief Gummies from Rare Cannabinoid Company contain hemp-derived Delta-9-THC, CBG oil, and CBD. They are all natural, vegan, and flavored with green apple.

Rare Cannabinoid Company, a leading innovator in the world of hemp-based products, is thrilled to announce the launch of its latest creation: THC + CBG Relief Gummies. This groundbreaking edible offers an enticing combination of Delta-9-THC, CBG, and CBD, providing consumers with an all-natural way to support their physical wellness.

HONOLULU, Nov. 29, 2023 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company, a leading innovator in the world of hemp-based products, is thrilled to announce the launch of its latest creation: THC + CBG Relief Gummies. This groundbreaking edible offers an enticing combination of Delta-9-THC, CBG, and CBD, providing consumers with an all-natural way to support their physical wellness.

THC + CBG Relief Gummies are the perfect fusion of THC Gummies and CBG Gummies, also with the benefits of CBD. Each gummy delivers 2.5mg of Delta-9-THC, 30mg of CBG, and 10mg of CBD in a delicious green apple flavor. With 30 gummies per bottle, it's a convenient and enjoyable way to experience the potential advantages of these cannabinoids.

"We are excited to introduce THC + CBG Relief Gummies to our valued customers. These gummies bring together the best of THC, CBG, and CBD, offering an enjoyable and effective way to support physical wellness."

Post this

Delta-9-THC, the primary cannabinoid in cannabis and hemp plants, is known for its potential to alleviate discomfort and promote a sense of euphoria. It interacts with cannabinoid receptors in the brain and nervous system, potentially reducing sensations of soreness and discomfort.

CBG, or Cannabigerol, is a rare cannabinoid found in cannabis and hemp. It offers potential benefits for relieving temporary discomfort and soreness, supporting joint and brain health, and promoting a sense of balance and calm.

The CBD in the hemp extract used in THC + CBG Relief Gummies is aimed at enhancing the overall experience through the entourage effect. These cannabinoids work synergistically, amplifying each other's effects and potentially providing even greater discomfort relief.

One of the most common questions regarding THC gummies is their legality. It's important to note that all THC Gummies by Rare Cannabinoid Company are made from Delta-9-THC naturally extracted from legal U.S.-grown industrial hemp. This THC is neither converted from CBD nor synthesized in any way. With less than 0.3% THC content, gummies are federally legal and available for shipment to all locations across the United States. However, due to international regulations, the Hawaiian brand regretfully cannot offer international shipping at this time.

"We are excited to introduce THC + CBG Relief Gummies to our valued customers," said a company spokesperson. "These gummies bring together the best of THC, CBG, and CBD, offering an enjoyable and effective way to support physical wellness. We are committed to providing high-quality, legal hemp products that can help people live their best lives."

Rare Cannabinoid Company also offers two other types of THC Gummies. Mood Gummies each contain 5mg Delta-9-THC as well as high levels of CBC oil for mood improvement and CBD oil. THC + CBN Sleep Gummies contain 5mg Delta-9-THC, 30mg CBN for rest, relaxation and sleep, and 10mg CBD oil each.

The company also offers THC-Free gummies, including THCV Gummies for energy and appetite control.

Rare Cannabinoid Company grew out of its sister brand, Hawaiian Choice CBD, and offers the largest selection of unique cannabinoid oils – such as CBDV and CBGA – as well as full and broad spectrum Hawaiian CBD oil tinctures, topicals, and Pet CBD.

To learn more about THC + CBG Relief Gummies and Rare Cannabinoid Company's other innovative hemp-based products, visit their website. For wholesale inquiries, visit Wellness Orders.

Rare Cannabinoid company is a trusted name in the hemp industry, dedicated to providing high-quality hemp-based products to promote health and wellness. With a commitment to innovation and excellence, Rare Cannabinoid Company continues to lead the way in the development of premium hemp-derived goods.

Media Contact

Jennifer Carlile, Rare Cannabinoid Company, 8087621313, [email protected], www.rarecannabinoidco.com

SOURCE Rare Cannabinoid Company

Modal title

THC + CBG Relief Gummies combine all the goodness of THC, CBG, and CBD for exercise recovery and physical wellness.
THC + CBG Relief Gummies combine all the goodness of THC, CBG, and CBD for exercise recovery and physical wellness.
THC + CBG Relief Gummies combine all the goodness of THC, CBG, and CBD for exercise recovery and physical wellness.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.